Covered recipient · General Payments record
HALEY BERRYMAN BLOOM
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$671.95
- Reported across 39 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $325.03 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $168.83 | 9 |
| GlaxoSmithKline, LLC. | $119.40 | 7 |
| Novo Nordisk AS | $22.37 | 1 |
| Exact Sciences Corporation | $14.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.96 | 01/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106778428 | CMS |
| ABBVIE INC. | $33.47 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106778432 | CMS |
| ABBVIE INC. | $30.61 | 05/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106778436 | CMS |
| ABBVIE INC. | $33.59 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106778441 | CMS |
| ABBVIE INC. | $15.26 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106778444 | CMS |
| ABBVIE INC. | $6.20 | 08/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106778448 | CMS |
| ABBVIE INC. | $11.63 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106778452 | CMS |
| ABBVIE INC. | $14.31 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106778456 | CMS |
| ABBVIE INC. | $7.80 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106778460 | CMS |
| Exact Sciences Corporation | $14.43 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114430346 | CMS |
| GlaxoSmithKline, LLC. | $14.31 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116212507 | CMS |
| GlaxoSmithKline, LLC. | $22.34 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116590201 | CMS |
| GlaxoSmithKline, LLC. | $15.74 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116636356 | CMS |
| GlaxoSmithKline, LLC. | $14.57 | 07/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116378294 | CMS |
| GlaxoSmithKline, LLC. | $18.50 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116371475 | CMS |
| GlaxoSmithKline, LLC. | $18.06 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115841778 | CMS |
| GlaxoSmithKline, LLC. | $15.88 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116469136 | CMS |
| Novo Nordisk Inc | $22.37 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100641456 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.